ALNYLAM PHARMACEUTICALS, INC.·4

Jun 22, 4:18 PM ET

CLARKE JOHN K 4

4 · ALNYLAM PHARMACEUTICALS, INC. · Filed Jun 22, 2018

Insider Transaction Report

Form 4
Period: 2018-06-20
Transactions
  • Award

    Stock Option (right to buy)

    2018-06-20+9,0009,000 total
    Exercise: $105.26From: 2019-06-20Exp: 2028-06-19Common Stock (9,000 underlying)

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT